You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
<h5class="description">A <sup>90</sup>Y radiolabeled monoclonal antibody targeting synovial sarcoma was used to treat relapsing metastases.</h5>
248
-
<h5class="description"><b>theranostic</b> procedure: in case of significant tumor uptake and favorable biodistribution obtained on SPECT images from <sup>111</sup>In-labeled injection, patients were treated with <sup>90</sup>Y.</h5>
248
+
<h5class="description"><b>Theranostic</b> procedure: in case of significant tumor uptake and favorable biodistribution obtained on SPECT images from <sup>111</sup>In-labeled injection, patients were treated with <sup>90</sup>Y.</h5>
249
249
<h5class="description">We provided comprehensive <b>Monte-Carlo 3D dosimetry</b> from time sequence of SPECT images. Time-activity curves extracted from <sup>111</sup>In-SPECT/CT in various organs and tumors were extracted and integrated. The estimated absorbed doses in normal tissues were compared to biological side effects and to the admitted maximal tolerated absorbed dose in normal organs. Results in the tumors were also compared to disease evolution.</h5>
0 commit comments